Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apis mellifica is a homeopathic medicine prepared from the whole honeybee (Apis mellifera). It is primarily used in homeopathy to relieve symptoms such as swelling, pain, and burning sensations resulting from insect stings or bites, as well as allergic reactions that are improved by cold applications. The preparation involves crushing the honeybee and diluting it extensively in alcohol and water until only trace amounts of the original substance remain. Its mechanism of action is not established according to conventional pharmacology; therapeutic claims are based on traditional homeopathic practice rather than accepted medical evidence. The extract contains various compounds found in bee venom such as melittin, hyaluronidase, phospholipases, histamine, dopamine, noradrenaline, and others[2][3][5]. Homeopathic products containing Apis mellifica are regulated for safety by dilution standards but are not evaluated for efficacy by regulatory agencies like the FDA[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Apis mellifica.